506 related articles for article (PubMed ID: 23160753)
1. Inflammatory bowel disease: an impaired barrier disease.
Jäger S; Stange EF; Wehkamp J
Langenbecks Arch Surg; 2013 Jan; 398(1):1-12. PubMed ID: 23160753
[TBL] [Abstract][Full Text] [Related]
2. Paneth's disease.
Wehkamp J; Stange EF
J Crohns Colitis; 2010 Nov; 4(5):523-31. PubMed ID: 21122555
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
Strober W; Asano N; Fuss I; Kitani A; Watanabe T
Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
[TBL] [Abstract][Full Text] [Related]
4. Defensin-immunology in inflammatory bowel disease.
Wehkamp J; Stange EF; Fellermann K
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S137-44. PubMed ID: 20117337
[TBL] [Abstract][Full Text] [Related]
5. Microbiota and mucosal defense in IBD: an update.
Stange EF; Schroeder BO
Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):963-976. PubMed ID: 31603356
[No Abstract] [Full Text] [Related]
6. Events at the host-microbial interface of the gastrointestinal tract. V. Paneth cell alpha-defensins in intestinal host defense.
Bevins CL
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G173-6. PubMed ID: 16014978
[TBL] [Abstract][Full Text] [Related]
7. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense.
Wehkamp J; Stange EF
Ann N Y Acad Sci; 2006 Aug; 1072():321-31. PubMed ID: 17057212
[TBL] [Abstract][Full Text] [Related]
8. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa.
Salzman NH; Underwood MA; Bevins CL
Semin Immunol; 2007 Apr; 19(2):70-83. PubMed ID: 17485224
[TBL] [Abstract][Full Text] [Related]
9. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.
Wehkamp J; Schmid M; Fellermann K; Stange EF
J Leukoc Biol; 2005 Apr; 77(4):460-5. PubMed ID: 15618294
[TBL] [Abstract][Full Text] [Related]
10. Defensin-mediated innate immunity in the small intestine.
Ouellette AJ
Best Pract Res Clin Gastroenterol; 2004 Apr; 18(2):405-19. PubMed ID: 15123078
[TBL] [Abstract][Full Text] [Related]
11. Intestinal barrier in inflammatory bowel disease.
Antoni L; Nuding S; Wehkamp J; Stange EF
World J Gastroenterol; 2014 Feb; 20(5):1165-79. PubMed ID: 24574793
[TBL] [Abstract][Full Text] [Related]
12. Innate antimicrobial host defense in small intestinal Crohn's disease.
Koslowski MJ; Beisner J; Stange EF; Wehkamp J
Int J Med Microbiol; 2010 Jan; 300(1):34-40. PubMed ID: 19850516
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage.
Tan G; Zeng B; Zhi FC
Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720
[TBL] [Abstract][Full Text] [Related]
14. The Interplay between Defensins and Microbiota in Crohn's Disease.
Coretti L; Natale A; Cuomo M; Florio E; Keller S; Lembo F; Chiariotti L; Pero R
Mediators Inflamm; 2017; 2017():8392523. PubMed ID: 28246439
[TBL] [Abstract][Full Text] [Related]
15. Alpha-defensins in the gastrointestinal tract.
Cunliffe RN
Mol Immunol; 2003 Nov; 40(7):463-7. PubMed ID: 14568393
[TBL] [Abstract][Full Text] [Related]
16. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
[TBL] [Abstract][Full Text] [Related]
17. [Chronic inflammatory bowel diseases (IBD): novel pathophysiological concepts and their clinical relevance].
Stange EF; Schmid M; Fellermann K; Wehkamp J
Praxis (Bern 1994); 2005 Sep; 94(37):1429-32. PubMed ID: 16193905
[TBL] [Abstract][Full Text] [Related]
18. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
Peyrin-Biroulet L; Chamaillard M
J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
[TBL] [Abstract][Full Text] [Related]
19. Innate immune functions of α-defensins in the small intestine.
Bevins CL
Dig Dis; 2013; 31(3-4):299-304. PubMed ID: 24246978
[TBL] [Abstract][Full Text] [Related]
20. Paneth cell defensins: key effector molecules of innate immunity.
Bevins CL
Biochem Soc Trans; 2006 Apr; 34(Pt 2):263-6. PubMed ID: 16545089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
